Back to today’s briefing

Story perspectives

Zoledronate Infusions Slash Fracture Risk in Postmenopausal Women

10/24/2025

45 9

Summary

Story summary

A study shows infrequent zoledronate acid infusions reduce fracture risk in low-risk postmenopausal women, mainly between years 5 and 10.
After 10 years, one or two infusions lowered fracture risk nearly 60% versus placebo.
The single infusion reduced the risk of any fracture by 30%.
The double infusion reduced fracture risk by 40%.
The trial involved women aged 50 to 60 in Auckland, New Zealand.

1 of 1

Story summary

A study shows infrequent zoledronate acid infusions reduce fracture risk in low-risk postmenopausal women, mainly between years 5 and 10.
After 10 years, one or two infusions lowered fracture risk nearly 60% versus placebo.
The single infusion reduced the risk of any fracture by 30%.
The double infusion reduced fracture risk by 40%.
The trial involved women aged 50 to 60 in Auckland, New Zealand.